Redesign Health Turned Starting a Healthcare Company Into a Repeatable Process
The New York studio has launched more than 60 healthcare companies since 2018 by treating the messy work of starting one - ideas, diligence, hiring, capital - as a system you can run again and again.
Most people treat starting a company the way they treat winning a lottery: you buy a ticket, you hope, and once in a while the numbers line up. Redesign Health decided that was a bad way to run an industry as important as healthcare. So instead of betting on the occasional brilliant founder, the New York firm built something stranger and more industrial - a studio that makes companies the way a workshop makes furniture, one after another, from a shared set of tools.
Founded in 2018, Redesign Health is a healthcare venture studio, sometimes called a venture builder. That label hides how odd the model really is. A traditional venture fund waits for founders to walk in with a pitch. Redesign Health tends to work the other way around: it generates the idea in-house, runs the market diligence, sketches the business, lines up seed capital, and then recruits a founding CEO to take the keys. The company, in other words, often exists on paper before the founder does.
Run that loop enough times and the numbers add up. The firm says it has launched more than 60 companies, that those companies have touched the lives of over 15 million patients, and that collectively they have generated more than $1 billion in revenue and raised over $1.5 billion from outside investors. Whatever you think of the model, it is no longer a small experiment.
01 / THE MODELCompany creation as an assembly line
The core insight is that most of the work in starting a healthcare company is not the idea. It is everything around the idea: understanding how payers actually reimburse, finding the first health-system pilot, hiring people who have shipped clinical software before, and surviving the regulatory maze long enough to sell something. Those tasks are painful, expensive, and - crucially - largely the same from one company to the next.
Redesign Health treats that repeated work as shared infrastructure. A new company launched through the studio can plug into a platform of operators, playbooks, finance and go-to-market support rather than reinventing each from a blank page. The founder still has to build the actual business, but starts several rungs up the ladder.
Healthcare is a stress test for the idea. In most industries a good product can find its own market. In healthcare, the person who uses a service, the person who prescribes it, and the person who pays for it are often three different parties, and the one holding the checkbook is usually an insurer or an employer with its own rules. Sales cycles run for years, pilots stall inside hospital committees, and a single compliance misstep can end a company. A studio that has walked dozens of startups through that gauntlet accumulates something a first-time founder cannot buy: pattern recognition for exactly where healthcare startups tend to die.
That system is what a founder is really buying into. In exchange, Redesign Health takes founding equity in the companies it launches, which is where its returns come from. It is closer to a startup factory that keeps a stake in everything it makes than to a fund that writes checks and waits.
02 / THE PORTFOLIOWhat actually comes off the line
The output is easier to grasp through the companies themselves. You have likely used one without knowing where it came from. The portfolio spans metabolic health, cancer navigation, elder care, claims processing and more.
The threads connecting them are deliberate. The firm's newest fund is organized around three bets it named explicitly: healthy aging, expanding the places where care can happen, and data interoperability - the plumbing that lets health records and systems actually talk to each other. If you want to know where a studio thinks the market is heading, watch what it builds on purpose rather than what founders happen to pitch.
It helps to be clear about who the customer is, because there are really two. The first is the founder or operator who partners with the studio to launch and run a company - the person Redesign Health is recruiting, equipping and betting on. The second is everyone the resulting companies serve: the patients, the providers trying to deliver care, the payers processing claims, and the employers buying benefits. The studio's own scoreboard - those 15 million patients - is measured through that second group, one portfolio company at a time.
03 / THE ROLODEXRelationships as a product
One of the least visible parts of the model is also one of the most valuable: institutional relationships. Redesign Health points to ties with large health systems and care organizations - names like Mayo Clinic, Cedars-Sinai, DaVita and UPMC - as connections its companies can draw on for clinical validation and distribution. Getting a meeting with a major hospital system is, for a two-person startup, often the hardest door to open. Handing a founder a warm introduction on day one is a genuine head start, and it is exactly the kind of asset a studio can build once and reuse many times.
04 / THE MONEYFunding the pipeline
Because the studio bankrolls its own companies, it has to raise real money to keep the line running. It has done so in steps: a large round in 2021 that roughly doubled the team, a follow-on in 2022 as the market tightened, and most recently a $175 million fund closed in December 2024, backed by Declaration Partners, Euclidean Capital and True North Advisors. That fund is earmarked to build around 20 more companies.
The economics are unusual for venture. A classic fund makes money on management fees and a slice of the upside. A studio like Redesign Health is betting that owning founding equity across dozens of companies - and improving each one's odds with shared support - beats spraying smaller stakes across a wider field. It is a more concentrated, more hands-on wager.
05 / THE PEOPLEFrom investor to factory owner
The firm was founded by Brett Shaheen, who came out of the investment world - earlier roles included the hedge fund Lone Pine Capital and the private-equity firm Carlyle - before deciding the bottleneck in healthcare was not capital or ideas but the repeatable process of turning ideas into launched companies. Redesign Health is his answer to that, now roughly 260 people spread across offices in New York, Los Angeles, Riyadh and Bengaluru.
Those far-flung offices point to the model's most interesting claim: that a company-building process can be packaged and shipped somewhere new. In 2024 the firm announced the Sanabil Venture Studio by Redesign Health, a partnership with Saudi Arabia's Sanabil Investments aimed at building 20 or more healthcare companies inside the kingdom. It is a test of whether the factory travels.
06 / THE NEXT TURNGoing AI-native
The studio has also started rebuilding itself. Redesign Health now describes itself as an AI-native company and points to an internal knowledge graph - built on millions of hours of expert research and a large web of institutional relationships - as the thing it feeds into ideation and diligence. The pitch to founders shifts accordingly: start your healthcare company on top of data and relationships you could never assemble alone.
It also sharpens the competitive question. Redesign Health sits between two worlds. On one side are other studios and builders such as AlleyCorp and Atomic; on the other, healthcare-focused funds and incubators like Rock Health, Flare Capital Partners and Define Ventures. What Redesign Health sells that a check alone cannot is the built-in scaffolding - and, increasingly, the software - around each new company.
07 / THE TIMELINEHow it got here
There are open questions, as there should be. Studios are capital-intensive, and the real test of the model is not how many companies get launched but how many reach durable scale and return the concentrated bets. The firm points to exits - the hearing-health company Lively, for instance, was acquired by GN Hearing - but the full ledger is still being written.
What is clear is the shape of the idea. Redesign Health looked at an industry where good companies are rare and hard to start, and decided the fix was not another fund but a machine for building them. Six years and 60-odd companies later, it is still running the loop.